Mark Levick is a seasoned pharmaceutical physician and board member, currently serving on the boards of InterAx Biotech and LEO Pharma, where they lead innovation initiatives. Formerly the CEO of Alvotech, Mark has held senior roles in global drug development at major biopharmaceutical companies, including Novartis and GSK. They are also an academic tutor and executive coach at the University of Cambridge, guiding C-suite executives and postgraduate students. With a strong foundation in clinical research and vaccine development, Mark's expertise spans multiple therapeutic areas and biopharmaceutical R&D.
This person is not in the org chart
This person is not in any teams
This person is not in any offices